View the Published
Tutivia™ Validation Study
Verici DX Logo

Events

American Transplant Congress

May 29, 2024
Verici Dx will attend the American Transplant Congress ("ATC") in Philadelphia hosted by the American Society of Transplantation and the American Society of Transplant Surgeons from 1-5 June 2024. We look forward to sharing our work on "Performance of Next-Gen Sequencing Biomarker Tutivia in the Setting of Kidney Delayed Graft Function" on Saturday 1 June […]
Keep Reading

AST Cutting Edge of Transplantation conference

February 23, 2024
We at Verici Dx are excited to be attending the AST Cutting Edge of Transplantation conference from Thursday, February 22nd to Saturday, February 24th. 
Keep Reading

Clarava™ poster presented at ASN Kidney Week 2023

November 20, 2023
Verici Dx attended and exhibited at the American Society of Nephrology’s annual conference, ASN Kidney Week, from 2-5 November 2023 in Philadelphia, PA. We were delighted to present a poster on the successful international clinical validation study for Clarava™, our pre-transplant blood-based prognostic test for the risk of early acute kidney transplant rejection. The poster, titled “Multi-Center […]
Keep Reading

Verici Dx attended and exhibited at ASN 2022 kidney week national conference

November 2, 2022
Verici Dx attended and exhibited at the ASN kidney week annual conference, from November 3rd to November 6th, 2022, at the Orlando Convention Center, in Orlando FL. Verici Dx, Renalytix, AST, and ASN, have partnered to create the Dr. Barbara T. Murphy endowed lectureship starting at ASN Kidney Week 2022. This lectureship commemorates Dr. Murphy […]
Keep Reading
crossmenuchevron-down